Our approach to innovation
We are the first MSK charity to actively support start-ups and entrepreneurs.
Our approach to innovation follows in the footsteps of our founder, Ronald Furlong, who combined a highly successful career as an orthopaedic surgeon with an equally successful career as an entrepreneur.
Our Ronald Furlong Fund supports the development of innovative and commercially viable ideas from UK start-ups.
We provide Early Career Researchers, who have successfully completed their research projects, with funding, education, mentoring and networking support to accelerate the translation of their research ideas into new products or services.
We work with partners to accelerate the translation of research ideas into new products or services.
Through our Ronald Furlong Fund we invest in entrepreneurial people and organisations delivering breakthrough MSK health innovations.
We have investments in a growing number of early stage companies pioneering breakthrough MSK technologies.
Deploys state-of-the-art AI and biomechanical modelling to help clinicians design better fitting prosthetic sockets.
Pioneering use of a nanoclay in injectable gel form that can carry biologic drugs capable of augmenting bone tissue regeneration.
Commercialising world’s first patented bio-specific solution for the targeted diagnosis and treatment of bone microfractures.
